| 1,25(OH)2D3 | 1,25-dihydroxyvitamin D3 |
| 1,25-D-MARRS | 1,25D-membrane-associated rapid response steroid-binding protein |
| 7-DHC | 7-dehydrocholesterol |
| AB | Antibody |
| ABPM | Ambulatory Blood pressure measurement |
| ACE | Angiotensin converting enzyme |
| AE | Adverse effects |
| AH | Arterial hypertension |
| Ang I | Angiotensin I |
| Ang II | Angiotensin II |
| ARB | Angiotensin receptor blocker |
| AT1R | Angiotensin II type 1 receptor |
| B-AR | Beta-adrenergic receptor |
| BARB | Beta-adrenergic receptor blockers |
| C39 | C. elegans miR-39 |
| CCB | Calcium channel blocker |
| CTGF | Connective Tissue Growth Factor |
| CVD | Cardiovascular disease |
| DBP | Diastolic blood pressure |
| EMT | Epithelial to Mesenchymal Transition |
| FGF23 | Fibroblast growth factor |
| FMD | Flow mediated dilatation |
| HR | Heart rate |
| HT | Hypertension |
| ICAM1 | Intracellular adhesion molecule 1 |
| O-LDL | Oxidized LDL |
| Pi | Serum inorganic phosphorus |
| PKC | Protein kinase C |
| PRA | Plasma renin activity |
| PRC | Plasma renin concentration |
| Pre-D3 | Pre Vitamin D3 |
| PTH | Parathyroid hormone |
| RAAS | Renin-angiotensin-aldosterone-system |
| RXR | Retinoid X receptor |
| SBP | Systolic blood pressure |
| SH | Secondary hypertension |
| SNP | Single nucleotide polymorphism |
| T2DM | Type 2 diabetes |
| VD3 | Vitamin D3 |
| VDBP | Vitamin D-binding protein |
| VDR | Vitamin D receptor |
| VitD | Vitamin D |